Newborn screening and genetic testing

Carole Kenner1, Maribeth Moran

  • 1University of Oklahoma Health Sciences Center, College of Nursing, Oklahoma City, OK 73117, USA. Carole-Kenner@ouhsc.edu

Insights

Newborn genetic screening offers early disease detection but raises ethical questions. This review guides clinicians on new testing advancements and best practices for genetic disease diagnosis in infants.

Area of Science:

  • Medical Genetics
  • Pediatrics
  • Bioethics

Background:

  • Advancements in newborn screening techniques enable early detection of numerous genetic diseases.
  • Early diagnosis presents complex ethical dilemmas concerning testing protocols, accessibility, and family counseling.
  • Lack of a national policy results in significant variability in state-level newborn screening programs.

Purpose of the Study:

  • To review current newborn genetic testing methodologies.
  • To address the ethical considerations and practical challenges associated with expanded newborn screening.
  • To provide a clinical framework for integrating new genetic testing knowledge into practice.

Main Methods:

  • Literature review of recent developments in newborn genetic screening.
  • Analysis of ethical frameworks and policy variations in newborn screening programs.
  • Synthesis of information to create a practical guide for clinicians.

Main Results:

  • Newborn genetic testing provides predictive information for a wide range of conditions.
  • Significant ethical and logistical challenges exist, including informed consent, test cost, and counseling.
  • Disparities in screening practices exist across different states due to the absence of national guidelines.

Conclusions:

  • Clinicians require updated knowledge on newborn genetic testing to navigate ethical complexities.
  • A standardized approach to newborn screening, addressing ethical and practical issues, is needed.
  • Integrating new screening technologies requires careful consideration of patient welfare and resource allocation.